SCHEMBL29550528

SCHEMBL29550528

COC(=O)c1ccc(OCCBr)cn1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.54
MAPT P10636 4/20 0.47
KDM4E B2RXH2 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
RAB9A P51151 1/20 0.43
DYRK1A Q13627 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
DRD3 P35462 1/20 0.40
POLB P06746 1/20 0.38
LCK P06239 1/20 0.38
PARP1 P09874 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23530000 1.00 MAPK1 (0.54) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL30402493 0.86 MAPK1 (0.56) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL361098 0.86 MAPK1 (0.56) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL22119231 0.86 MAPK1 (0.56) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL11375152 0.84 MAPK1 (0.54) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL20423622 0.84 MAPK1 (0.54) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL1173618 0.84 MAPK1 (0.54) MAPK1MAPTKDM4EL3MBTL1RAB9A
SCHEMBL31620610 0.82 MAPK1 (0.59) MAPK1KDM4EL3MBTL1RAB9ADYRK1A
SCHEMBL10270980 0.82 MAPK1 (0.59) MAPK1KDM4EL3MBTL1RAB9ADYRK1A
SCHEMBL13466852 0.81 MAPK1 (0.57) MAPK1MAPTKDM4EL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114302886-B Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-03-22 CN disclosed
CN-114302886-A Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2022-04-08 CN disclosed